Earnings Dashboard
REGN
upcomingREGENERON PHARMACEUTICALS INC
Time TBDlarge capWednesday, April 29, 2026
Expected Move Analysis
Expected
7.7%
Current Stock Price
$707.06
Expected Move
±7.7%
±$54.59
IV Rank
85
High
Put/Call Ratio
1.15
Bearish bias
Analysis & Commentary
REGENERON PHARMACEUTICALS INC (REGN) reports earnings Wednesday . Consensus EPS estimate is $5.96.
IV Rank is elevated at 85, indicating options premiums are pricing in a larger-than-usual move. This creates an edge for premium sellers — the IV crush after the event can be significant.
A short strangle with strikes beyond the ±7.7% expected move could capture the IV crush. This is a higher-risk play — consider defined-risk alternatives or strict position sizing.
Enter the position 1-2 days before earnings to capture the final IV ramp. Plan to close the morning after the report once IV collapses — don't hold hoping for further decay.